Expression of tissue inhibitors of metalloproteinase 1 (TIMP-1) in gastric cancer tissue

Folia Histochemica et Cytobiologica

Volumn 47, Issue 3, 2009, Pages 511-516

  Mroczko, Barbara ^a   Łukaszewicz Zajaç, Marta ^a   Groblewska, Magdalena ^a   Czyzewska, Jolanta ^a   Gryko, Mariusz ^a   Guzińska Ustymowicz, Katarzyna ^a   Kemona, Andrzej ^a   Kȩdra, Bogusław ^a   Szmitkowski, Maciej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Gastric cancer; Tissue inhibitor of matrix metalloproteinase 1

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE STUDY; STOMACH CANCER;

EID: 77149126428     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0071-6     Document Type: Article

References (15)

1. th Edition. Philadelphia: Lippincott-Raven Publisher, 1997, pp. 1021-22.
2. Seiki M, Yana I. Role of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Sci. 2003;94:569-574.
3. Crawford HC, Matrisian LM. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis. 1995;14:234-245.
4. Wagenaar-Miller RA, Gorden L, Matrisian LM. Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev. 2004;23:119-135.
5. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997;74:111-122.
6. De Mingo M, Morán A, Sánchez-Pernaute A et al. Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma. Hepatogastroenterol. 2007;54:315-319.
7. Işlekel H, Oktay G, Terzi C, Canda AE, Füzün M, Küpelioglu A. Matrix metalloproteinase-9, -3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables. Cell Biochem Funct. 2007; 25:433-441.
8. Seo YS, Park JJ, Kim JH et al. Usefulness of MMP-9/TIMP-1 in predicting tumor recurrence in patients undergoing curative surgical resection for gastric carcinoma. Dig Dis Sci. 2007;52:753-759.
9. Biswas C, Zhang Y, DeCastro R et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995;55:434-439.
10. Jass JR, Sobin LH. WHO International Histological Classification of Tumors. Histological typing of Intestinal Tumors. New York, Springer-Verlag, 1989. [11] Mehta CR, Patel NR. Algorithm 643: FEXACT: A FORTRAN subroutine for Fisher's exact test on unordered r x c contingency tables. ACM Transactions on Mathematical Software.1986;12:154-161.
11. Bonomi P. Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer. Semin Oncol. 2002;29:78-86.
12. Zhang S, Li L, Lin JY, Lin H. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma. World J Gastroenterol. 2003;9:899-904.
13. Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Miyagi Y. Protein levels of tissue inhibitor of metalloproteinase-1 in tumor extracts as a marker for prognosis and recurrence in patients with gastric cancer. Gastric Cancer. 2006;9:106-113.
14. Joo YE, Seo KS, Kim HS, Rew JS, Park CS, Kim SJ. Expression of tissue inhibitors of metalloproteinases (TIMPs) in gastric cancer. Dig Dis Sci. 2000;45:114-121.
15. Suzuki Y, Ohtani H, Mizoi T et al. Cell adhesion molecule expression by vascular endothelial cells as an immune/inflammatory reaction in human colon carcinoma. Jpn J Cancer Res. 1995;86:585-593.